Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.
There is currently no completely effective therapy available for metastatic pheochromocytomas or paragangliomas. Increasing understanding of the germline and somatic mutations leading to pheochromocytoma and paraganglioma development has revealed crucial insights into the molecular pathology of thes...
Main Authors: | Nölting, S, Grossman, AB |
---|---|
Format: | Journal article |
Sprog: | English |
Udgivet: |
2012
|
Lignende værker
-
Pheochromocytomas and paragangliomas: assessment of malignant potential.
af: Korevaar, T, et al.
Udgivet: (2011) -
Pheochromocytomas and paragangliomas: assessment of malignant potential
af: Korevaar, T, et al.
Udgivet: (2011) -
Current management of pheochromocytoma/paraganglioma: a guide for the practicing clinician in the era of precision medicine
af: Nölting, S, et al.
Udgivet: (2019) -
Pheochromocytomas and secreting paragangliomas
af: Gimenez-Roqueplo Anne-Paule, et al.
Udgivet: (2006-12-01) -
Treatment of metastatic pheochromocytoma and paraganglioma with I-131-meta-iodobenzylguanidine (MIBG)
af: Kaltsas, G, et al.
Udgivet: (2003)